e-learning
resources
Munich 2006
Sunday 03.09.2006
Asthma models – mechanisms of airway inflammation and experimental therapies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung inflammation depends on the acylation of lipooligosaccharide (LOS)
S. Hadina, P. S. Thorne, P. B. McCray Jr., J. P. Weiss (Iowa City, United States Of America)
Source:
Annual Congress 2006 - Asthma models – mechanisms of airway inflammation and experimental therapies
Session:
Asthma models – mechanisms of airway inflammation and experimental therapies
Session type:
Thematic Poster Session
Number:
1339
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hadina, P. S. Thorne, P. B. McCray Jr., J. P. Weiss (Iowa City, United States Of America). Lung inflammation depends on the acylation of lipooligosaccharide (LOS). Eur Respir J 2006; 28: Suppl. 50, 1339
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
LOS:MD-2 complex induces more lung inflammation than LOS
in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 300s
Year: 2006
Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Nontypeable
haemophilus influenzae
(NTHi) and lung oxidative stress
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 and killing of non-typeable haemophilus influenzae (NTHi) is reduced after 14 days exposure to TNF-α and IL-1β in primary bronchial epithelial cells (PBEC)
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
A molecule derived from mycobacterium tuberculosis
Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Induction of neutrophil extracellular traps (NETs) by the pneumococcal toxin, pneumolysin (Ply)
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Mechanisms responsible for surfactant changes in sepsis-induced lung injury
Source: Eur Respir J 2005; 26: 1074-1079
Year: 2005
Airway MUC2 is decreased in patients with severe COPD and bacterial colonization
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Involvement of asparatic acid racemization and isomerization in the pathogenesis of COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Glucose catabolism by respiration assisted fermentation leading to acetate production has a key contribution to chronic patient airway infection by Haemophilus influenzae
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Role of peroxiredoxin 6 in lipopolysaccharide-induced mucin production in mice
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
LSC - 2019 - Surfactant protein SP-D to the rescue of NETosis and NET-induced lung surfactant inactivation
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019
Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Smoking alters alpha1-antitrypsin in alveolar macrophages possibly promoting misfolding
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Alteration of the immune response to streptococcus pneumoniae during COPD exacerbation in mice
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Lung function, symptoms and inflammatory biomarkers in patients with bronchiectasis (brx) with and without chronic pseudomonas aeruginosa (psa) colonisation
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
LATE-BREAKING ABSTRACT: Protective effects of surfactant protein D (SP-D) treatment in 1,3-ß-glucan-modulated allergic inflammation
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept